Federspiel B - Search Results

1

Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1.

Døssing KB, Binderup T, Kaczkowski B, Jacobsen A, Rossing M, Winther O, Federspiel B, Knigge U, Kjær A, Friis-Hansen L. Døssing KB, et al. Among authors: federspiel b. Genes (Basel). 2014 Dec 24;6(1):1-21. doi: 10.3390/genes6010001. Genes (Basel). 2014. PMID: 25546138 Free PMC article.

2

Somatostatin Analogue Treatment Primarily Induce miRNA Expression Changes and Up-Regulates Growth Inhibitory miR-7 and miR-148a in Neuroendocrine Cells.

Døssing KBV, Kjær C, Vikeså J, Binderup T, Knigge U, Culler MD, Kjær A, Federspiel B, Friis-Hansen L. Døssing KBV, et al. Among authors: federspiel b. Genes (Basel). 2018 Jul 4;9(7):337. doi: 10.3390/genes9070337. Genes (Basel). 2018. PMID: 29973528 Free PMC article.

3

18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors.

Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. Binderup T, et al. Among authors: federspiel b. Clin Cancer Res. 2010 Feb 1;16(3):978-85. doi: 10.1158/1078-0432.CCR-09-1759. Epub 2010 Jan 26. Clin Cancer Res. 2010. PMID: 20103666 Clinical Trial.

4

Gene Expression of Glucose Transporter 1 (GLUT1), Hexokinase 1 and Hexokinase 2 in Gastroenteropancreatic Neuroendocrine Tumors: Correlation with F-18-fluorodeoxyglucose Positron Emission Tomography and Cellular Proliferation.

Binderup T, Knigge UP, Federspiel B, Sommer P, Hasselby JP, Loft A, Kjaer A. Binderup T, et al. Among authors: federspiel b. Diagnostics (Basel). 2013 Oct 29;3(4):372-84. doi: 10.3390/diagnostics3040372. Diagnostics (Basel). 2013. PMID: 26824929 Free PMC article.

5

Functional imaging of neuroendocrine tumors: a head-to-head comparison of somatostatin receptor scintigraphy, 123I-MIBG scintigraphy, and 18F-FDG PET.

Binderup T, Knigge U, Loft A, Mortensen J, Pfeifer A, Federspiel B, Hansen CP, Højgaard L, Kjaer A. Binderup T, et al. Among authors: federspiel b. J Nucl Med. 2010 May;51(5):704-12. doi: 10.2967/jnumed.109.069765. Epub 2010 Apr 15. J Nucl Med. 2010. PMID: 20395333 Free article.

6

Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive Review.

Ilett EE, Langer SW, Olsen IH, Federspiel B, Kjær A, Knigge U. Ilett EE, et al. Among authors: federspiel b. Diagnostics (Basel). 2015 Apr 8;5(2):119-76. doi: 10.3390/diagnostics5020119. Diagnostics (Basel). 2015. PMID: 26854147 Free PMC article. Review.

7

Prognostic Value of 18F-FLT PET in Patients with Neuroendocrine Neoplasms: A Prospective Head-to-Head Comparison with 18F-FDG PET and Ki-67 in 100 Patients.

Johnbeck CB, Knigge U, Langer SW, Loft A, Berthelsen AK, Federspiel B, Binderup T, Kjaer A. Johnbeck CB, et al. Among authors: federspiel b. J Nucl Med. 2016 Dec;57(12):1851-1857. doi: 10.2967/jnumed.116.174714. Epub 2016 Jul 28. J Nucl Med. 2016. PMID: 27469355 Free article. Clinical Trial.

8

P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms.

Nielsen K, Binderup T, Langer SW, Kjaer A, Knigge P, Grøndahl V, Melchior L, Federspiel B, Knigge U. Nielsen K, et al. Among authors: federspiel b. BMC Cancer. 2020 Jan 10;20(1):27. doi: 10.1186/s12885-019-6498-z. BMC Cancer. 2020. PMID: 31924180 Free PMC article.

9

¹⁸F-FDG PET is Superior to WHO Grading as a Prognostic Tool in Neuroendocrine Neoplasms and Useful in Guiding PRRT: A Prospective 10-Year Follow-up Study.

Binderup T, Knigge U, Johnbeck CB, Loft A, Berthelsen AK, Oturai P, Mortensen J, Federspiel B, Langer SW, Kjaer A. Binderup T, et al. Among authors: federspiel b. J Nucl Med. 2021 Jun 1;62(6):808-815. doi: 10.2967/jnumed.120.244798. Epub 2020 Oct 16. J Nucl Med. 2021. PMID: 33067340 Free PMC article.

10

Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms.

Holmager P, Langer SW, Kjaer A, Ringholm L, Garbyal RS, Pommergaard HC, Hansen CP, Federspiel B, Andreassen M, Knigge U. Holmager P, et al. Among authors: federspiel b. Curr Treat Options Oncol. 2022 Jun;23(6):806-817. doi: 10.1007/s11864-022-00969-x. Epub 2022 Apr 1. Curr Treat Options Oncol. 2022. PMID: 35362798 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters